Find your next favorite podcast

Become a member today and read free for 30 days
The Jab: Why can’t more be made?: Thousands are dying each day amid vaccine shortages. Would a patent waiver save lives?


Jayati Ghosh of the University of Massachusetts Amherst says liberating IP is an urgent moral issue. Richard Hatchett, CEO at CEPI, disagrees.


Alok Jha and Natas...

The Jab: Why can’t more be made?: Thousands are dying each day amid vaccine shortages. Would a patent waiver save lives? Jayati Ghosh of the University of Massachusetts Amherst says liberating IP is an urgent moral issue. Richard Hatchett, CEO at CEPI, disagrees. Alok Jha and Natas...

FromEconomist Radio


The Jab: Why can’t more be made?: Thousands are dying each day amid vaccine shortages. Would a patent waiver save lives? Jayati Ghosh of the University of Massachusetts Amherst says liberating IP is an urgent moral issue. Richard Hatchett, CEO at CEPI, disagrees. Alok Jha and Natas...

FromEconomist Radio

ratings:
Length:
40 minutes
Released:
May 10, 2021
Format:
Podcast Episode

Description

Thousands are dying each day amid vaccine shortages. Would a patent waiver save lives?Jayati Ghosh of the University of Massachusetts Amherst says liberating IP is an urgent moral issue. Richard Hatchett, CEO at CEPI, disagrees.Alok Jha and Natasha Loder are joined by Edward Carr, our deputy editor, and economics columnist Ryan Avent.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science and data newsletters at economist.com/simplyscience and economist.com/offthecharts
 See acast.com/privacy for privacy and opt-out information.
Released:
May 10, 2021
Format:
Podcast Episode